Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (131-140 of 250) with videos related to

Pageof 25
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaRob J van Klaveren, Joachim G J V Aerts, Hein de Bruin, et al.
Insights Into Imaging|April 13, 2018
Imaging of urgencies and emergencies in the lung cancer patientBruno De Potter, Jef Huyskens, Birgitta Hiddinga, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)B Biesma, C Manegold, H J M Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2009
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trialsJ Francart, E Vaes, S Henrard, et al.
Respiratory Medicine|February 1, 1995
Atypical bronchial carcinoid tumoursN J Struyf, J P Van Meerbeeck, M R Ramael, et al.
Familial Cancer|July 2, 2018
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesotheliomaMarieke Hylebos, Ken Op de Beeck, Jenneke van den Ende, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2005
A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndromeI Noorlander, J W Elte, O C Manintveld, et al.
Diagnostic Cytopathology|July 20, 2006
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundantJ G J V Aerts, M Delahaye, T H van der Kwast, et al.
Frontiers in Oncology|May 23, 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath ResearchEline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Pageof 25

Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaRob J van Klaveren, Joachim G J V Aerts, Hein de Bruin, et al.
Insights Into Imaging|April 13, 2018
Imaging of urgencies and emergencies in the lung cancer patientBruno De Potter, Jef Huyskens, Birgitta Hiddinga, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)B Biesma, C Manegold, H J M Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2009
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trialsJ Francart, E Vaes, S Henrard, et al.
Respiratory Medicine|February 1, 1995
Atypical bronchial carcinoid tumoursN J Struyf, J P Van Meerbeeck, M R Ramael, et al.
Familial Cancer|July 2, 2018
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesotheliomaMarieke Hylebos, Ken Op de Beeck, Jenneke van den Ende, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2005
A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndromeI Noorlander, J W Elte, O C Manintveld, et al.
Diagnostic Cytopathology|July 20, 2006
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundantJ G J V Aerts, M Delahaye, T H van der Kwast, et al.
Frontiers in Oncology|May 23, 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath ResearchEline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Pageof 25